US Regulatory Shift Sends Tilray Shares into a Tailspin

Tilray shares are facing severe downward pressure following an unexpected legislative development in the United States. A newly proposed federal budget measure threatens to reimpose penalties on specific hemp-derived products starting in 2026, presenting a direct challenge to a core segment of Tilray’s business operations.

Investors responded swiftly to the regulatory uncertainty, triggering a significant sell-off. Trading activity on Thursday revealed the depth of market concern:

• Share value plummeted from $1.23 to $1.13
• Trading volume surged dramatically, exceeding 55 million shares
• Sustained selling pressure indicates a continuing negative trend

The intensity of the reaction underscores investor apprehension regarding the potential long-term implications of the Read more...